At a glance
- Originator Auckland Cancer Society Research Centre
- Class Cytostatics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Jul 1998 Profile reviewed
- 17 Mar 1995 Preclinical development for Cancer in New Zealand (Unknown route)